SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 206.01-0.4%Nov 19 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: N who wrote (13932)2/3/1998 9:55:00 AM
From: Henry Niman   of 32384
 
Nancy, I'm still trying to get details on a time line for this year. I did talk to IR yesterday, and they expect 2Q to be very busy as far as clinical results are concerned (for Panretin and Targretin). The Panretin NDA is on track for this year and clinical data will be present at a conference on April 8 as well as ASCO in May and the AIDS International conference in June.

SA indicated that the data will make believers out of the street as far as LGND profitability is concerned and she expect more analysts to come out with earnings figures in agreement with Bear Stearns' projections (including a profit next year).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext